In previous publications, EZH2, a cancer-associated protein with histone-methyltransferase activity, was overexpressed and was related to poor prognosis in LIHC.[35] As for NQO1,[36] PLK1[37] and BSG,[38] the prognostic performance and expression status were similar with EZH2. This evidence concerns the gene EZH2 and cancer.